Current research haveing on Nexaph small protein chains, a unique type of agents showing remarkable capability for modulating different disease mechanisms. Compared to traditional small molecule methods, Nexaph peptides provide enhanced targeting and lesser side effects, allowing them a truly encouraging avenue for next-generation therapeutic innov